Alex Aleshin


Alex Aleshin, VP of Oncology at Natera

Dr. Alexey Aleshin has led the oncology clinical development efforts at Natera, Inc. since 2018. Prior to this, he worked on the various novel ctDNA technologies while at Stanford University. He remains a clinical adjunct faculty in the division of Hematology at Stanford, where his work focuses on novel diagnostics assays for treatment decision support in hematologic malignancies. He received a B.A. in Statistics from UC Berkeley and his M.D./M.B.A. degrees at UCLA. He completed his clinical training in internal medicine and hematology/oncology at Stanford University.

Listen to the interview with Alex (published April 2022) https://mendelspod.com/podcasts/largest-study-its-kind-shows-ctdna-be-hi...



mendelspod
-->